Navigation Links
Study of Williams syndrome patients reveals specific gene's role in intelligence
Date:4/22/2010

SALT LAKE CITY, UT April 21, 2010 Although genetics is the most significant known determinant of human intelligence, how specific genes affect intelligence remains largely unknown. A multi-institution team led by a University of Utah (U of U) USTAR researcher has found that the brain gene STX1A plays a significant role in the level of intelligence displayed by patients with Williams Syndrome (WS). The study may have implications for the understanding of intelligence and treatment of neurological disease in the general population.

Researchers at UCLA, Cedars-Sinai Medical Center, Salk Institute, and the U of U found that variations in the expression of STX1A could account for 15.6 percent of cognitive variation in a group of 65 WS patients, a very high level of confidence in comparison to prior genetic studies. STX1A is involved in the electrochemical processes that occur at the brain's synapses.

The research team is under the direction of Julie R. Korenberg, Ph.D., M.D., Brain Institute USTAR investigator and professor of pediatrics at the U of U School of Medicine. The team published the study on April 21, 2010 in the open access / online scientific jounal PLoS ONE.

The study describes a new approach in determining the relationship between gene expression and intelligence in patients with WS, a neurodevelopmental disorder caused by the deletion of only two dozen genes from chromosome 7, a tiny fraction of the almost 30,000 genes found in humans. WS patients have one less copy each of the genes in question than does the general population.

WS patients typically exhibit an IQ of 60, compared to an average of 100 for the general population. WS patients tend to be highly verbal and social, but have difficulty with numbers, visual-spatial perception and memory.

"Williams Syndrome patients are missing a very, very small amount of genetic material," said Korenberg. "In almost all other respects, their make-up is the same as the general population, so we knew to take a very close look at a small number of genes. We analyzed ten different genes, but the data spoke, and STX1A clearly stood out in relation to the different patients' intelligence levels," Korenberg said.

STX1A has a fundamental role in the brain's neurotransmission machinery. It supports the process by which electrical signals speed from one neuron to the next. "In terms of the brain, we're talking about a basic utility when we look at STX1A," Korenberg said.

The study points the way to further research that may have long-range benefits for WS patients as well as the general population. "This study shows in part how Nature's hand shapes intelligence at the synapse. Monitoring gene expression may provide unique insights into the neurobiology and genetics of intelligence in WS subjects and possibly the general population," Korenberg said.

Korenberg suggested there may be pharmaceutical treatments in the future that could help enhance synaptic function. "New studies could suggest ways to help people whose brain function is lacking, such as in Williams Syndrome, or people who are losing brain function, such as in Alzheimer's Disease," she said.

The research team overcame obstacles with some creative problem solving, Korenberg said. Since brain cells from live patients were unavailable for study, lymphoblastoid cells from the lymph system grown in culture provided the genetic material to analyze.

In addition, the researchers developed a more precise measure of WS intelligence test data, using a technique called Principal Component Analysis (PCA). In comparison to standardized IQ tests best suited for the general population, the PCA approach was able to better represent a baseline pattern of intelligence in WS patients. The WS baseline adjusted for relative strengths and weaknesses in the study group, and was able to illuminate the impact of specific genes like STX1A more accurately.


'/>"/>

Contact: Jason Youngstrom
jason.youngstrom@utah.edu
801-587-1201
University of Utah Health Sciences
Source:Eurekalert

Related medicine news :

1. Study Finds Patients Breathe Easier After Weight-Loss Surgery
2. Knowledge is power in Penn State blood pressure study
3. Breast density change linked to cancer development in WHI hormone replacement study
4. Ovarian cancer study offers vital clues for new therapies
5. NFL gives $1 million unrestricted gift to Boston University to study impact of brain injuries
6. Study cautions: Psychotropic medications overprescribed to children
7. Study finds treatment-resistant ringworm prevalent among children in metro elementary schools
8. Convenience drives US women to buy over-the-counter contraception in Mexico, study finds
9. New phase II study supports potential of gs-9450 as new treatment option for steatohepatitis
10. BU Study Contributes to Online Health Education Debate
11. CWRU study examines effectiveness of telemonitoring vital signs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2017)... ... , ... LARKR™ , an innovative new smartphone app providing on-demand talk ... to join its online treatment platform. , Launching in just a few days, ... number of people in need nationwide, and to supplement their traditional practices. Joining this ...
(Date:6/26/2017)... ... June 26, 2017 , ... KICKICO , a protocol ... that pledges to solve many catastrophic issues within funding campaigns. KICKICO developers are testing ... notion of crowdfunding - the raising of funds through the power of many - ...
(Date:6/25/2017)... ... , ... FCPX LUT Vintage Volume 2 for Final Cut Pro X allows ... 2 contains 60 different color-grade presets, giving editors multiple options for adding different color ... out subjects, plus much more. FCPX LUT Vintage Volume 2 is designed for any ...
(Date:6/25/2017)... ... 2017 , ... Republicans in the United States Senate on Thursday released their ... Reconciliation Act. It differs significantly from the American Health Care Act, which the House ... or the House will have to take up the Senate version as-is, if it ...
(Date:6/25/2017)... ... ... CareSet Labs released the Root NPI Graph today at the 2017 Academy ... of the Doctor Referral teaming dataset commonly available from Medicare. , Originally created through ... “Doctor Referral Dataset” as released by Medicare and “DocGraph” as released by Trotter, the ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... 2017 The Bio Supply Management Alliance (BSMA) ... Fremont and the Biomedical Manufacturing Network to ... California by providing a platform ... fostering workforce development. The primary focus of this alliance ... as well as small and mid-sized biomedical companies. ...
(Date:6/13/2017)... June 13, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... announced that the U.S. Food and Drug Administration (FDA) has ... 2015 relating to its Zhejiang, China ... "The successful clearance of the Warning Letter related ... facility is a measure of the progress we have made ...
(Date:6/11/2017)... 2017  Eli Lilly and Company (NYSE: LLY ... studies of galcanezumab, an investigational treatment for the prevention ... several key secondary endpoints for galcanezumab compared to placebo ... (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented today at ... Boston . "The ...
Breaking Medicine Technology: